Pfizer Amgen: That Pfizer’s Seagen Bet Could Lead
Pfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Understanding which cash back card offers the most rewards can help you maximize your earnings. Explore your best options now!
27,114 articlesPfizer’s Seagen integration is starting to pay off, signaling a shift in oncology bets as Amgen pursues a rebuild thr...
Two parallel paths are emerging in legal AI: one focused on enterprise rigor and governance, the other on broad, open...
C3.AI reports two consecutive quarterly revenue declines, forcing investors to reassess its enterprise AI strategy as...
Netflix reports revenue growth driven by ads and a leaner strategy, while Disney posts margins and park revenue gains...
Vice Capital Markets launches a public daily Par Note Rate benchmark, providing a market-based view of mortgage prici...
As AI use expands from training to real-world deployment, memory players like Micron face a pivotal moment. This arti...
When the chips slide, investors hunt for the best pick. This guide weighs Marvell and Broadcom as the market cools, o...
A fresh partnership announcement sent nano nuclear energy stock higher as investors weigh the promise of small modula...
In the fast-moving world of micro-scale tech, rapid micro (rpid) earnings calls can signal whether a company is susta...
TIAA's leader recalls starting with a modest $26,000 salary and still maxing out her 401(k), underscoring the long-te...
SpaceX is expanding beyond rockets with a bold $60B Cursor deal. This strategic shift could redefine how investors va...
Howard Marks has publicly shifted his stance on AI after a Claude tutorial, urging investors to balance opportunity w...